Enhabit, Inc.(EHAB)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,192 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
EHAB Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Enhabit, Inc. (EHAB), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EHAB at 54.8/100 on a 32-signal composite quality model, placing it at rank #1,192 of 2,879 stocks — the top half of the AI-ranked universe. EHAB scores in the top quartile across institutional flow (76.1). Areas of concern include earnings quality (30.0) and revenue growth (33.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Enhabit, Inc. reports quarterly revenue of $264.8M, net income of $19.2M, free cash flow of $32.7M. Top institutional holders of EHAB by reported 13-F value include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock,, BALYASNY ASSET MANAGEMENT L.P., based on the most recent SEC filings. EHAB trades on the NYSE exchange and files with the SEC under CIK 1803737. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EHAB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Enhabit, Inc. directly from SEC EDGAR. Enhabit, Inc.'s 13F Pro composite quality score has ranged between 8 and 55 since 2023, currently 54.8 — an improving long-term trajectory across 47 quarterly and live scoring snapshots.
Revenue
Q1 2026
$264.8M
Net Income
Q1 2026
$19.2M
Free Cash Flow
Q1 2026
$32.7M
ROIC
Q1 2026
3.1%
D/E Ratio
Q1 2026
0.77
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+2.4% YoYNet Income
+97.1% YoYOperating Income
+114.0% YoYEPS (Diluted)
+97.1% YoYTotal Assets
-4.8% YoYTotal Debt
-13.0% YoYOp. Cash Flow
+38.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $1.06B +2.4% | $1.03B -1.1% | $1.05B -2.3% | $1.07B -0.7% | $1.08B | — |
| Net Income | $-4.6M +97.1% | $-156.2M -94.0% | $-80.5M -99.3% | $-40.4M -153.9% | $75.0M | — |
| Operating Income | $16.1M +114.0% | $-115.1M -141.8% | $-47.6M -317.5% | $-11.4M -111.1% | $102.7M | — |
| EPS (Diluted) | $-0.09 +97.1% | $-3.11 -93.2% | $-1.61 -98.8% | $-0.81 -153.6% | $1.51 | — |
| Total Assets | $1.17B -4.8% | $1.23B -14.5% | $1.43B -6.1% | $1.53B | — | — |
| Total Debt | $448.3M -13.0% | $515.4M -6.7% | $552.6M -5.2% | $583.1M | — | — |
| Operating Cash Flow | $70.7M +38.1% | $51.2M +5.8% | $48.4M -39.6% | $80.1M +221.7% | $24.9M | — |
AI Insight: EHAB Financial Trends
Debt reduction accelerates and Q1 2026 operating income hits $29M — strongest in the eight-quarter window — signaling operational recovery despite recurring Q4 losses.
• Total debt fell steadily from $536M in Q2 2024 to $429M in Q1 2026, a $107M reduction over eight quarters.
• Operating income rebounded sharply to $29M in Q1 2026 after back-to-back losses of -$98M and -$41M in Q3–Q4 2024.
• Operating cash flow surged to $35M in Q1 2026, the highest in the series, up from -$4M in Q4 2024.
• Revenue has remained range-bound between $254M and $270M across all eight quarters, indicating limited top-line growth.
⚠ Q4 has produced operating losses in both Q4 2024 (-$41M) and Q4 2025 (-$33M), suggesting a persistent seasonal earnings drag.
⚠ Equity declined from $674M in Q2 2024 to $534M in Q4 2025 due to cumulative net losses, only partially recovering to $554M in Q1 2026.
⚠ Revenue of $265M in Q1 2026 is essentially flat versus $261M in Q2 2024 — organic growth momentum remains absent.
AI Insight: EHAB Ratio Trends
Q1 2026 marks EHAB's strongest quarterly profitability in the visible dataset, with operating margin hitting 11.1% and ROIC reaching 11.9%, rebounding sharply from Q4 2025's impairment-driven losses.
• Operating margin surged to 11.1% in Q1 2026, the highest in the dataset, recovering from -12.3% in Q4 2025.
• ROIC expanded from 6.5% in Q3 2025 to 11.9% in Q1 2026, the strongest reading across all periods shown.
• D/E ratio declined steadily from 0.98 in Q4 2024 to 0.77 in Q1 2026, signaling gradual deleveraging.
• TTM net profit margin remains -0.3%, reflecting drag from Q3 2024 (-43.5%) and Q4 2025 (-14.3%) large losses.
⚠ Recurring deep Q3/Q4 losses — Q3 2024 and Q4 2025 both saw operating margins below -12% — suggest seasonal or impairment risk.
⚠ NPM dropped from 6.9% in Q1 2025 to 1.9% in Q2 2025, indicating Q1 strength may partially reflect one-off items.
⚠ Sustained positive ROIC above 6% for three consecutive quarters through Q3 2025 before Q4 reversal warrants monitoring for durability.
Get alerted when EHAB's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Enhabit, Inc. including:
Top Institutional Holders of EHAB
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$66.9M4,747,746 shBlackRock, Inc.
$54.4M3,863,842 shBALYASNY ASSET MANAGEMENT L.P.
$37.3M2,645,992 shAREX Capital Management, LP
$35.1M2,494,155 shVANGUARD CAPITAL MANAGEMENT LLC
$30.1M2,137,944 shUBS Group AG
$29.7M2,108,496 shJANA Partners Management, LP
$29.5M2,090,412 shFIL Ltd
$28.6M2,028,929 shDIMENSIONAL FUND ADVISORS LP
$21.0M1,492,081 shQube Research & Technologies Ltd
$20.8M1,474,716 sh
| Fund | Value | Shares |
|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $66.9M | 4,747,746 |
| BlackRock, Inc. | $54.4M | 3,863,842 |
| BALYASNY ASSET MANAGEMENT L.P. | $37.3M | 2,645,992 |
| AREX Capital Management, LP | $35.1M | 2,494,155 |
| VANGUARD CAPITAL MANAGEMENT LLC | $30.1M | 2,137,944 |
| UBS Group AG | $29.7M | 2,108,496 |
| JANA Partners Management, LP | $29.5M | 2,090,412 |
| FIL Ltd | $28.6M | 2,028,929 |
| DIMENSIONAL FUND ADVISORS LP | $21.0M | 1,492,081 |
| Qube Research & Technologies Ltd | $20.8M | 1,474,716 |
More Healthcare Companies
View all Healthcare →Put EHAB on your watchlist
Track score changes the day Enhabit, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is EHAB a good stock to buy?
13F Pro's AI-powered analysis of Enhabit, Inc. (EHAB) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EHAB are available on the EHAB stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own EHAB?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EHAB. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Enhabit, Inc.'s investment landscape.